DN Delta 9 Cannabis Inc

DELTA 9 CANNABIS INC. (TSX: DN) (OTCQB: DLTNF) (“Delta 9” or the “Company”), is pleased to support Bill 10 proposed by the Manitoba Conservative Government which would repeal the 6% Social Responsibility Fee (the “SRF”) on gross retail cannabis revenues. The Bill, if passed, would eliminate SRF owing from retailers retroactive to January 1, 2022. During the public consultations on Bill 10, cannabis retailers, including Delta 9, have encouraged the government to waive the fees owed for 2022 and 2023.

"We would like to thank the Manitoba Conservative Government and Minister Cullen for proposing the amendment to make the SRF repeal retroactive to January 2022. Cannabis retailers have voiced the need for this type of financial support to invest that capital back into their business, to lower prices, educate the public, create more jobs, and continue to put an end to the illegal market,” said John Arbuthnot, CEO of Delta 9. “When the social responsibility fee is eliminated, Manitoba will have one of the most competitive pricing programs for cannabis in Canada. This is a strong demonstration from the Manitoba Conservative Government that they have listened to the concerns of stakeholders and have brought forward swift supports for the cannabis retail sector.”

The social responsibility fee was introduced in 2018 to fund the social costs of public education, safety, and health for cannabis and eliminate the Manitoba PST charge. When Bill 10 passes, the Manitoba government is expected to enter the federal excise tax agreement which is expected to be revenue neutral for the province going forward.

For more information contact:Investor & Media Contact:Ian Chadsey VP Corporate AffairsMobile: 204-898-7722E-mail: ian.chadsey@delta9.ca

About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 95,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQB under the symbol “DLTNF”. For more information, please visit www.invest.delta9.ca.

Disclaimer for Forward-Looking Information

Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company’s future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include (i) statements relating to amendments to Bill 10 to repeal the SRF and (ii) statements relating to the approval and passage of Bill 10. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including the Company’s actual financial results being different from its estimates as well as all risk factors set forth in the annual information form of Delta 9 dated March 31, 2023 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.